Fact CheckerSign in

NCT06571292Completed

Effect of the Dose of Training in Upper Limb Motor Recovery After Stroke.

Effect of the Dose of a Task Specific Training Program and Armeo Spring on Upper Limb Motor Recovery in Chronic Stroke: Randomized Clinical Trial

Source: ClinicalTrials.gov · Last updated 4 Mar 2026

Brief summary (registry, in English)

The aim of the study is to analyse the effect of intensive training on upper limb function in stroke patients. 20 stroke patients were randomly divided into two groups: the intensive group and the control group. The control group will be trained with robotic exoskeleton for upper limbs and task specific training, 3 sessions per week for 4 weeks, for 1 hour per day. The intensive group will do robotic exoskeleton for upper limbs and task specific training, 5 sessions a week for 4 weeks, for 2 hours a day.

Status (registry)
Completed
Study type
Interventional
Enrollment
20 (actual)
First submitted
11 Jul 2024
Start date
5 Jul 2024
Primary completion date
30 Aug 2024
Lead sponsor
Universidad de Zaragoza
Diseases
Stroke
NCT number
NCT06571292

What you commit to

  • Study type: Interventional
  • Participants enrolled: 20
  • From 5 Jul 2024 to the primary completion date, 30 Aug 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Treatment with botulinum toxin 3 months prior to the intervention.

Other

  • Persons diagnosed with other pathologies, other than those indicated in the inclusion criteria.
  • Montreal Cognitive Assessment (MoCA), the minimum score to be achieved will be 22 points.
  • Severe difficulties in understanding language (aphasia).
  • Behavioural or behavioural disturbance.

Who the study is looking for

  • People diagnosed with stroke (ischaemic or haemorrhagic).
  • Patients in a subacute or chronic state.
  • Patients must be over 18 years of age and under 80 years of age.
  • Patients with impaired functionality of the upper limb.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Zaragoza
Coordinator of this site? Confirm its status
ZaragozaSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.